Originally published In Press as doi:10.1074/jbc.M000679200 on May 22, 2000
J. Biol. Chem., Vol. 275, Issue 35, 27155-27164, September 1, 2000
Tyrosine Phosphorylation of Paxillin
Is Involved in
Temporospatial Regulation of Paxillin-containing Focal Adhesion
Formation and F-actin Organization in Motile Cells*
Kuniaki
Nakamura
,
Hajime
Yano
,
Hiroshi
Uchida
,
Shigeru
Hashimoto
,
Erik
Schaefer§, and
Hisataka
Sabe
¶
**
From the
Department of Molecular Biology, Osaka
Bioscience Institute, Suita, Osaka 565-0874, the ¶ Graduate
School of Biostudies, Kyoto University, Sakyoku, Kyoto 606-8502, and
the
Precursory Research for Embryonic Science and Technology,
Japan Science and Technology Corporation, Kyoto 619-0237, Japan, and
§ BioSource International,
Hopkinton, Massachusetts 01748
Received for publication, January 24, 2000, and in revised form, April 26, 2000
 |
ABSTRACT |
Temporal and spatial regulation of actin-based
cytoskeletal organization and focal adhesion formation play an
essential role in cell migration. Here, we show that tyrosine
phosphorylation of a focal adhesion protein, paxillin, crucially
participates in these regulations. We found that tyrosine
phosphorylation of paxillin was a prominent event upon integrin
activation during epithelial-mesenchymal trans-differentiation and cell
migration. Four major tyrosine phosphorylation sites were identified,
and two of them were highly inducible upon integrin activation.
Paxillin exhibits three distinct subcellular localizations as follows: localization along the cell periphery colocalized with circumferential actin meshworks, macroaggregation at focal adhesions connected to actin
stress fibers, and diffuse cytoplasmic distribution. Tyrosine
phosphorylation of paxillin localized at the cell periphery and focal
adhesions was shown using phosphorylation site-specific antibodies.
Mutations in the phosphorylation sites affected the peripheral
localization of paxillin and paxillin-containing focal adhesion
formation during cell migration and cell-cell collision, accompanied by
altered actin organizations. Our analysis indicates that
phosphorylation of multiple tyrosines in paxillin
is necessary for
the proper function of paxillin and is involved in the temporospatial regulation of focal adhesion formation and actin cytoskeletal organization in motile cells.
 |
INTRODUCTION |
Cell migration plays an essential role in a wide variety of
physiological and pathological processes of multicellular organisms, such as embryogenesis, organogenesis, wound repair, inflammatory processes, and cancer invasion and metastasis. Cell locomotion is
primarily mediated by binding of integrin to the extracellular matrices
and an actin cytoskeleton-based force-generation system (1-5). Actin
cytoskeletal organization also plays an important role in cell
migration. Activation of intracellular GTPase/GTP-binding proteins,
including the Rho family GTPases, has been shown to play a pivotal role
in intracellular regulation of the dynamic properties of actin-based
cytoskeletal organization, as well as the formation of focal adhesion
complexes (6-8). Similarly, the activity of small GTP-binding ARF
family proteins also participates in actin reorganization and focal
complex formation (9-12). In addition, a number of effector proteins
for these GTP-binding proteins have been identified. However, despite
intense investigation of these underlying pathways, the mechanisms
regulating spatial and temporal control of focal adhesion formation and
actin cytoskeletal organization are not yet well established.
Higher vertebrates utilize a succession of tissue transformations
between epithelium and mesenchyme during embryogenesis (13). During
trans-differentiation of epithelial cells to mesenchymal cells
(epithelial-mesenchymal trans-differentiation;
EMT),1 cadherin-mediated
cell-cell adhesions almost disappear, and the expression and the
avidity of integrins are highly augmented, thus enabling the cell to
move (14). Several cytokines, such as TGF-
1-3, TGF-
, Mullerian
inhibitory factor, and acidic FGF, have been shown to induce EMT
in vitro; and several oncogenes, including v-src,
v-ras, and v-mos, have also been shown to induce EMT (14). The EMT system in vitro is thus well established
and provides a way to analyze the early events during integrin
activation and cell migration, accompanied by a change from the
cadherin-mediated cell-cell adherent phenotype to the integrin-mediated
cell-migratory phenotype. Increasing numbers of signaling molecules
have been shown to participate in integrin signaling and
integrin-mediated cell migration (3, 15-19). Moreover,
integrin-mediated cell migration signaling appears to intercommunicate
with and thus be regulated by a number of different intracellular
signals generated by cytokines, growth factors, cadherins, and other
integrins (20). One of the early events that occurs upon integrin
activation is the tyrosine phosphorylation of several
integrin-associated proteins, including paxillin (21). Paxillin is
composed of multiple isoforms, but the
isoform appears to play a
more dominant role as compared with other isoforms (22, 23). Tyrosine
phosphorylation of paxillin has been shown to be important for the
formation of focal adhesions and cell cycle progression into S-phase
(21, 24), and several tyrosine kinases have been implicated in paxillin phosphorylation (24-26). Lack of paxillin tyrosine phosphorylation in
neutrophils isolated from a patient with a leukocyte adhesion deficiency also implicates its importance in leukocyte function (27).
Several signaling molecules, such as Csk and v-Crk, have been shown to
bind to tyrosine-phosphorylated paxillin via their src homology 2 (SH2)
domains. Paxillin also interacts with several focal adhesion proteins
with scaffold and/or catalytic signaling properties, including
vinculin, talin, integrin
1, focal adhesion kinase (Fak), and c-Src (15, 28). Moreover, papilloma virus E6 protein
binds to paxillin, and this binding correlates with disruption of the
actin cytoskeletal architecture in virus-infected cells (29, 30). Thus,
paxillin acts as an adaptor molecule and seems to be essential for
integrin signaling.
In this report, we used in vitro EMT of normal murine
mammary gland cells, NMuMG (31), as a model to explore the mechanism of
regulation of cell migratory properties that accompany integrin activation. We found that tyrosine phosphorylation of the
isoform of paxillin is one of the most prominent events during EMT, together with increased tyrosine phosphorylation of p130Cas. Similar
patterns of phosphorylation were also observed when these epithelial
cells were migrating actively. We have identified four major tyrosine
phosphorylation sites in paxillin
, and we showed that multiple
sites of paxillin phosphorylation seem to play important roles in the
formation of paxillin-containing focal adhesions and F-actin
organization in motile cells.
 |
EXPERIMENTAL PROCEDURES |
Cells--
NMuMG cells (CRL 1639) with a passage number of 15 were obtained from the American Type Culture Collection (Manassas, VA) and grown in Dulbecco's modified Eagle's medium (with 4.5 g
glucose/liter) supplemented with 10% fetal calf serum (HyClone
Laboratories, Inc., Logan, UT), 10 µg/ml insulin (Life Technologies,
Inc.), 100 µg/ml penicillin, and 100 units/ml streptomycin at
37 °C in 5% CO2. After the initial expansion for 3 days
cells were frozen in aliquots, and in each experiment, cells were
cultured no longer than 2 weeks by subculturing at a dilution of
1:10-1:20 every 3rd day following 0.25% trypsin/EDTA treatment.
Trypsinization was done for 10 min at ambient temperature.
For trans-differentiation into the mesenchymal phenotype, 8 × 105 NMuMG cells were seeded in a 9-cm culture dish (Becton
Dickinson), and 24 h later 2 ng/ml TGF-
1 (R & D Systems,
Minneapolis, MN) was added, and cells were cultured further for 48 h as described previously (31). For analysis of the epithelial
phenotype, 8 × 105 cells were seeded in a 9-cm
culture dish and cultured for 3 days. Parental NMuMG cells, both in
epithelial and mesenchymal forms, reached confluence under these
conditions. To examine cells under sparse culture conditions, 2 × 105 cells were seeded initially and then processed as
above. Under these conditions, apparent cell confluence is less than
20%.
cDNA Clones and Expressions--
Enhanced green fluorescent
protein (EGFP; CLONTECH, Palo Alto, CA)-tagged
paxillin
isoform cDNA in pBabePuro vector (32) was described
previously (23). Each potential tyrosine phosphorylation site (33) was
mutated into phenylalanine singly or in various combinations by using
the following designations: 31F, 40F, 118F, 181F, 2X(31/118F),
2Y(40/181/434/488F), 4X (31/40/118/181F), and 6X(31/40/118/181/434/488F) (see Fig. 2A). All mutant
cDNAs were made with the Altered Sites II in Vitro
Mutagenesis System (Promega Corp., Madison, WI) with appropriate
synthetic DNA fragments.
Each wild-type and mutant paxillin cDNA in the pBabePuro vector was
transfected into BOSC 23 cells, and each recombinant virus was
collected as described (34). Virus titers were in the range of
105-106 infectious units/ml. NMuMG cells were
infected with these viruses, and selection was imposed 2 days later
with 1 µg/ml puromycin (Sigma) for 1 more week. During selection,
passage and expansion of cells were performed when necessary. Cells
then were frozen in aliquots, and in each experiment cells were thawed
and cultured for no longer than 2 weeks.
Antibodies--
Rabbit anti-paxillin antibody (Ab199-217),
which recognizes both the
and
isoforms, and the paxillin
-specific antibody were described previously (22, 23). Rabbit
antibodies against phosphotyrosine and focal adhesion kinase (Fak) were
described previously (35, 36). Anti-p130Cas antibody was a
gift from Dr. H. Hirai (Tokyo University) or purchased from
Transduction Laboratories Inc. (Lexington, KY). Monoclonal anti-paxillin antibody (Transduction Laboratories),
anti-phosphotyrosine (clone 4G10, Upstate Biotechnology, Lake Placid,
NY), and Cy2- or Cy3-conjugated secondary antibodies (Jackson
ImmunoResearch) were purchased from commercial sources. Phosphorylation
site-specific antibodies that recognize paxillin when phosphorylated on
tyrosine 31 (anti-pY31 paxillin) or tyrosine 118 (anti-pY118 paxillin) were obtained from BIOSOURCE International
(Camarillo, CA). These antibodies are affinity-purified (using both
negative and positive affinity purification methods) rabbit polyclonal
antibodies that are highly selective for the targeted phosphorylation
site, as demonstrated by peptide competition studies and through use of site-directed mutants possessing a tyrosine to phenylalanine
substitution at the phosphorylation site (see Fig. 3A).
Immunoblotting Analysis--
Cell lysates were prepared with
RIPA buffer (1% Nonidet P-40, 0.1% SDS, 1% sodium deoxycholate, 150 mM NaCl, 20 mM Tris-HCl (pH 7.4), 5 mM EDTA, 1 mM Na3VO4, 1 mM phenylmethylsulfonyl fluoride, 1% aprotinin, 2 µg/ml
leupeptin, and 3 µg/ml pepstatin A) as described previously (35). For
immunoblotting, 20 µg of cell lysate was boiled in Laemmli's SDS
sample buffer, separated by 8% SDS-PAGE, and transferred to membrane
filters (Immobilon P, Millipore Corp., Bedford, MA), and subjected to
immunoblotting analysis as described previously (35). Antibodies
retained on the filter membranes were visualized by horseradish
peroxidase-conjugated donkey anti-rabbit or anti-mouse IgG secondary
antibodies (Jackson ImmunoResearch) coupled with an enzyme-linked
chemiluminescence method according to the manufacturer's instructions
(Amersham Pharmacia Biotech). For immunoprecipitation, 500 µg of each
cell lysate was used.
Indirect Immunofluorescence--
8 × 104 NMuMG
cells were seeded into each 3.5-cm culture dish, possessing a hole at
the bottom where a number 0 glass coverslip was attached (MatTek Corp.,
Ashland, MA). After 24 h, cells were treated with or without
TGF-
1 and cultured further for 48 h, as described above. To
analyze motile cells, confluent cultures of cells were scratched
manually with the needle of a 10-µl syringe (Hamilton Co., Carson,
NV). Wound regions were allowed to heal for 0-16 h prior to analysis.
Cells then were fixed with 3.7% paraformaldehyde (Sigma) in HBSS for
20 min at room temperature. Fixed cells were permeabilized with 0.1%
Triton X-100 in HBSS for 2 min. After being washed with HBSS, cells
were soaked in HBSS containing 10% skim milk (blocking solution) for
30 min followed by incubation with 2 µg/ml anti-paxillin antibody in
blocking solution for 1 h at room temperature. Cells then were
washed with HBSS and incubated with Cy2- or Cy3-conjugated secondary
antibody at 1:400 dilution in blocking solution for 1 h at room
temperature. F-actin was visualized by incubation for 1 h with
Texas Red-X phalloidin (Molecular Probes, Eugene, OR) at 1:200
dilution. After washing, the samples were mounted in 50%
glycerol/phosphate-buffered saline, and confocal images were acquired
using a confocal laser-scanning microscope (model 510; Carl Zeiss,
Inc., Oberkochen, Germany). For double staining with phosphotyrosine
and paxillin, 4G10 and rabbit anti-paxillin antibody (Ab199-217) were
used. Rabbit anti-paxillin tyrosine 31- or tyrosine 118-phosphospecific
antibody and mouse anti-paxillin antibody were used to detect tyrosine
phosphorylation of paxillin.
For time-lapse microscopy, cells were incubated on a glass bottom 35-mm
dish on the plate heated at 37 °C, and the fluorescence of
EGFP-paxillin in a living cell was observed by confocal laser scanning
microscopy (model 510 using the supplied software) at an interval of 1 min. Each figure of microscopic analysis shows representative results
that were independently confirmed by both mass cell cultures of the
original BOSC virus-infected cells and with several independent cell
clones isolated from the original infected cells.
 |
RESULTS |
Prominent Changes in the Levels of Tyrosine Phosphorylation of
Paxillin and p130Cas during EMT of NMuMG Cells--
In
order to explore the cellular events during integrin activation and
cell migration, we employed an in vitro EMT system of NMuMG
cells (31) as an experimental model. In this system, treatment of cells
with TGF-
1 causes trans-differentiation of NMuMG cells from the
epithelial phenotype into the mesenchymal phenotype, which is
accompanied by a change from cadherin-mediated cell-cell adhesion to
integrin-mediated cell-substratum adhesion. To identify the major
factors involved in this model of EMT, we first analyzed a series of
proteins involved in cell adhesion. It has already been shown that
expression levels of cadherin and integrin are reciprocally changed and
that expressions of fibronectin and vimentin are increased during EMT
(31). We confirmed these changes with our cell culture system (data not
shown). We also examined several other proteins related to cadherin and
integrin, including desmoglein,
-,
-, and
-catenins, ERM
(ezrin, radixin and moesin), tensin, talin, p130Cas, Fak,
Pyk2/Cak-
, p120Cas, vinculin, and paxillin
; and we
found that the expression levels of these proteins remained essentially
unchanged during EMT (data not shown). Rodent cells express two
isoforms of paxillin,
and
(23). The
isoform of paxillin was
found to be much less abundant than the
isoform, comprising less
than 10% of the total paxillin expressed in NMuMG cells, but its
expression was augmented 2-3-fold during EMT (data not shown).
It is well documented that integrin activation is accompanied by
cellular protein tyrosine phosphorylation. We therefore examined cellular protein tyrosine phosphorylation during EMT of NMuMG cells. As
shown in Fig. 1A, tyrosine
phosphorylation on several proteins of about 120-140 and about 70-80
kDa were highly augmented during EMT. We identified these bands as
paxillin because immunodepletion of paxillin from the cell lysates
diminished the bands almost completely (Fig. 1B). Blotting
of anti-paxillin immunoprecipitates with the anti-phosphotyrosine
antibody 4G10 revealed that paxillin was tyrosine-phosphorylated at a
low level in the epithelial phenotype and became highly
tyrosine-phosphorylated in the mesenchymal phenotype (Fig.
1C). No monospecific antibodies for the
isoform of
paxillin were available, but antibodies that recognize only the
isoform exist, enabling determination of the position of the
isoform on the blotting filters (23). An alignment of
tyrosine-phosphorylated bands and the isoform
band indicated that
most of the tyrosine phosphorylation occurred on the
isoform (data
not shown). On the other hand, in order to address the 120-140-kDa
protein bands, we examined p130Cas and p125Fak,
both of which are implicated in cell migratory activity (37-40). We
found that tyrosine phosphorylation of p130Cas was also
highly augmented during EMT, whereas tyrosine phosphorylation of Fak
was almost unchanged (Fig. 1C).

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 1.
Change in tyrosine phosphorylation of
paxillin is prominent during in vitro EMT or
cell migration of NMuMG cells. A and B,
anti-phosphotyrosine immunoblotting analysis of NMuMG cells of the
epithelial phenotype ( TGF) or the mesenchymal phenotype
(+TGF, 2 ng/ml for 48 h at 37 °C). A,
RIPA cell lysates (20 µg each) were prepared, separated on SDS-PAGE,
and subjected to immunoblotting analysis as described under
"Experimental Procedures." B, same analysis performed
with RIPA cell lysates that were pre-depleted of paxillin using the
mouse monoclonal anti-paxillin antibody. Signals were generated using
the generic rabbit polyclonal anti-phosphotyrosine antibody. Molecular
sizes determined using marker proteins are shown on the
left. C, levels of tyrosine phosphorylation of
paxillin, p130Cas, and Fak from NMuMG cells were analyzed
by immunoprecipitating (i.p.) each protein from crude cell
lysates using the appropriate antibody, followed by SDS-PAGE and
sequential immunoblotting using an anti-phosphotyrosine antibody (4G10)
and the protein-specific antibodies. D, tyrosine
phosphorylation of paxillin and p130Cas from NMuMG cells,
cultured under confluent or sparse conditions, was determined as
described above (C) and under "Experimental
Procedures."
|
|
When epithelial cells are cultured under sparse conditions, their
integrins become activated, and the cells migrate. Indeed, we were able
to document by video recording that these cells migrate as actively as
cells of the mesenchymal phenotype (data not shown). We thus analyzed
epithelial cells under sparse culture conditions, and we found that
paxillin and p130Cas were both highly
tyrosine-phosphorylated (Fig. 1D).
Identification of Tyrosine Phosphorylation Sites in Paxillin
--
We then focused on tyrosine phosphorylation of the
isoform of paxillin, one of the most prominent changes upon integrin activation during EMT or cell migration. We made a series of
EGFP-tagged paxillin
cDNAs (23). EGFP-paxillin has been
expressed in several cell lines, including NMuMG, with no detectable
differences from endogenous paxillin in subcellular localization and
biochemical properties, other than the expected increase in molecular
mass (see Ref. 23; also see Figs.
2B and 7B). Six
tyrosine residues have been suggested as potential phosphorylation
sites in the
isoform of paxillin (33). To study the role of these
specific sites, a series of mutant cDNAs were constructed in which
each tyrosine residue was changed to a phenylalanine, either singly or
in various combinations (see YF mutants, Fig. 2A). Each
cDNA was packaged using a BOSC23-derived retrovirus and then
expressed in NMuMG cells to examine its tyrosine phosphorylation. As
shown in Fig. 2B, disruption of all six residues eliminated
tyrosine phosphorylation almost completely in both the epithelial and
the mesenchymal cells. However, we found that disruption of the
amino-terminal four tyrosine residues was sufficient for the
elimination of tyrosine phosphorylation, and disruption of the two
carboxyl-terminal tyrosine residues did not affect phosphorylation
(Fig. 2B and data not shown). We also found that mutations
in any one of these four amino-terminal residues reduced the
phosphorylation, although none of these individual substitutions could
completely eliminate the phosphorylation (Fig. 2B).

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 2.
Identification of the major tyrosine
phosphorylation sites of paxillin during
in vitro EMT of NMuMG cells. A,
schematic drawing of the proposed tyrosine phosphorylation sites.
Tyrosine residues mutated to phenylalanine in each mutant cDNA of
paxillin are shown. B, detection of tyrosine
phosphorylation of each paxillin mutant expressed in NMuMG cells
under conditions that induce either the epithelial ( TGF)
or mesenchymal (+TGF) phenotype. Each paxillin cDNA
fused to EGFP was expressed in NMuMG cells using the retrovirus
infection system as described under "Experimental Procedures." Both
endogenous (closed arrowhead) and exogenous (open
arrowhead) paxillin proteins were immunoprecipitated using
monoclonal anti-paxillin antibody from RIPA cell lysates, separated on
SDS-PAGE, and subjected to sequential immunoblotting analysis using an
anti-phosphotyrosine (4G10) and anti-paxillin 199-217
(pax) antibodies.
|
|
Amino acid sequences following these tyrosine residues are
Y31SYP, Y40QEI, Y118SFP, and
Y181GVP. Each of these sites has been implicated in the
creation of binding sites for several SH2-containing proteins as
follows: Y31SYP for Crk, Y40QEI for Src,
Y118SFP for Crk, and Y181GVP for Crk and
phospholipase C
(26, 33). The Y31SYP and the
Y118SFP have a common motif of YS
P (where
is
aromatic amino acid). The level of tyrosine phosphorylation on the 2X
mutant (for which residues 31 and 118 were both mutated) was largely
reduced and little change was observed during EMT (Fig. 2B).
On the other hand, the 2Y mutant (for which residues 31 and 118 remained unchanged but the other tyrosine residues were all mutated)
was well phosphorylated, and the phosphorylation was further increased
during EMT (Fig. 2B). We also examined other possible
combinations of mutations in these four residues (data not shown), and
we collectively concluded that the major tyrosine phosphorylation sites
in the
isoform of paxillin are residues 31, 40, 118, and 181 in
NMuMG cells, and the phosphorylation of residues 31 and 118 is highly
inducible during EMT.
Phosphorylation of tyrosine 31 and 118 and its augmentation during EMT
were confirmed using phosphorylation site-specific antibodies that
selectively recognize paxillin when phosphorylated at these sites. The
specificity of each of these antibodies was confirmed by immunoblotting
analysis using the YF mutants of paxillin
(Fig.
3A). A comparable increase in
paxillin tyrosine phosphorylation was also confirmed in epithelial
cells cultured under sparse conditions (Fig. 3B). We thus
focused on the role of phosphorylation of tyrosines 31 and 118 in the
remainder of this study. A similar analysis of phosphorylation on
tyrosine 40 and 181 would also be interesting; however, antibodies that
selectively detect phosphorylation at these sites were not yet
available.

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 3.
Paxillin tyrosine phosphorylation
detected using phosphorylation site-specific antibodies.
A, assessment of the specificity of the phosphorylation
site-specific antibodies. NMuMG cells expressing wild-type
EGFP-paxillin or the corresponding YF mutants were treated with
TGF- to induce differentiation to the mesenchymal phenotype. RIPA
cell lysates (20 µg each) then were prepared, separated on SDS-PAGE,
and subjected to immunoblotting analysis using anti-paxillin,
anti-phosphotyrosine (4G10), or phosphorylation
site-specific (targeting tyrosine phosphorylation of paxillin at
residue 31 (pY31) or 118 (pY118)) antibodies.
B, increased phosphorylation on tyrosine 31 and 118 of
paxillin during EMT and cell migration. Cell lysates were prepared
from confluent or sparse cells as described under "Experimental
Procedures" and subjected to immunoprecipitation with anti-paxillin
antibody, followed by immunoblotting analysis using the phosphorylation
site-specific antibodies to paxillin described above.
|
|
Paxillin Localized to the Cell Periphery and Focal Adhesions Is
Tyrosine-phosphorylated--
Formation of focal adhesions, as well as
actin stress fibers, seemed to be tightly coupled with the cell
migratory phenotype in NMuMG cells (Fig.
4, A and B).
Sedentary NMuMG epithelial cells at confluence possessed only marginal
amounts of actin stress fibers and paxillin-containing focal adhesions.
Paxillin in these sedentary epithelial cells was diffusely distributed
throughout the cytoplasm. On the other hand, NMuMG cells differentiated
to the mesenchymal phenotype by TGF-
treatment possessed significant amounts of both actin stress fibers and paxillin-containing focal adhesions (Fig. 4A).

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 4.
Intracellular localization of paxillin and
its tyrosine phosphorylation. A, loss of actin stress
fibers and paxillin-containing focal adhesions in confluent
NMuMG cells with epithelial phenotype. Cells (8 × 105 in a 9-cm culture dish) treated either with or without
TGF were fixed, labeled, and subjected to microscopic analysis as
described under "Experimental Procedures." F-actin was visualized
with Texas Red-conjugated phalloidin. Paxillin was visualized
with anti-paxillin antibody followed by Cy2-conjugated anti-mouse IgG.
Differential interference contrast (DIC) images of the same
field were shown in the right column. B,
colocalization of paxillin with F-actin in motile epithelial cells.
Cells were induced to migrate by manually scratching confluent cell
cultures and fixed 4 h later as described under "Experimental
Procedures." Paxillin and F-actin were visualized as above, and their
merged image is shown. C, detection of tyrosine
phosphorylation of paxillin localized at the cell periphery and in
focal adhesions. Migrating epithelial cells, prepared as above, were
labeled with anti-phosphotyrosine antibody (4G10) or
phosphorylation site-specific antibodies against the tyrosine 31 (pY31) and tyrosine 118 (pY118) (shown in
red) as described under "Experimental Procedures."
Endogenous paxillin is shown in green. Each right
column is the merged image of the left and middle
columns. Scale bars represent 20 µm.
|
|
To examine the role of tyrosine phosphorylation of paxillin during cell
migration, cells were induced to undergo directed migration by manually
scratching confluent cell cultures, as commonly performed in a wound
healing assay. In epithelial cells induced to migrate, paxillin
exhibits three distinct subcellular localizations (Fig. 4B
and also see Fig. 6A). First, paxillin localized laterally along the cell periphery apparently colocalized with a circumferential meshwork of actin filaments. Paxillin also localized to focal adhesions
as macroaggregates, connecting to actin stress fibers and, finally, was
diffusely distributed in the cytoplasm. Paxillin-containing focal
adhesions were not formed at the cell periphery but formed at least
several micrometers away. To examine which fraction of paxillin is
tyrosine-phosphorylated, cells were double immunolabeled with
anti-paxillin antibody and anti-phosphotyrosine antibodies. As shown in
Fig. 4C, no significant labeling with phosphotyrosine antibody was detected on paxillin diffusely distributed in the cytoplasm, whereas paxillin localized at the cell periphery and at
focal adhesions seemed to be tyrosine-phosphorylated. By using the
phosphorylation site-specific antibodies against tyrosine 31 or
tyrosine 118 of paxillin, phosphorylation on these residues was
confirmed in situ, with signals again localized to paxillin molecules localized at the cell periphery and at focal adhesions (Fig.
4C).
Mutations in the Tyrosine Phosphorylation Sites of Paxillin
Affect Paxillin-containing Focal Adhesion Formation and Actin
Cytoskeletal Organization in Motile Cells---
We next examined
the effects of mutations in the tyrosine phosphorylation sites of
paxillin
in motile cells. Our results described above indicated
that paxillin molecules that were tyrosine-phosphorylated seemed to be
colocalized with F-actin structures. We thus examined the
actin-cytoskeletal architecture in cells expressing the paxillin YF mutants.
Cells expressing wild-type and mutant paxillin and grown to confluence
did not contain detectable amounts of actin stress fibers or
paxillin-containing focal adhesions (Fig.
5, 0 h). However, unlike
wild-type cells, we found that cells expressing the 2X mutant formed
paxillin-containing macroaggregate structures at the cell periphery
(2-4 h after scratching, Figs. 5 and
6B). These macroaggregates
connected to actin stress fibers (Fig. 5). In addition, other focal
adhesion proteins, including vinculin, colocalized with these
macroaggregates (data not shown), indicating that these macroaggregates
correspond to focal adhesions. By merging the fluorescence images from
the EGFP-tagged 2X mutant with that of the cell body, we found that
these paxillin-containing focal adhesion structures did not correspond
to membrane protrusions of filopodia (see Fig.
7A). However, note that cells
expressing the 2X mutant did exhibit several filopodia-like structures
at their leading edges (Fig. 7A), which was seldom seen with
normal NMuMG cells. On the other hand, circumferential actin fibers and
paxillin that normally localized laterally along the cell periphery
were almost undetectable in the 2X mutant cells. Moreover, sizes of the
paxillin-containing focal adhesions were noticeably larger than those
observed in the wild-type cells. In addition, actin stress fibers
appeared to be bundled to a much greater extent as compared with the
wild-type cells. Indeed, in these cells, some of the stress fibers
crisscrossed with each other, and in other instances, two actin fibers
were sometimes connected to single focal adhesion. Both phenomena were seldom seen in wild-type cells.

View larger version (89K):
[in this window]
[in a new window]
|
Fig. 5.
Mutations of paxillin tyrosine
phosphorylation sites alter intracellular dynamics of paxillin and
actin cytoskeletal organization in motile NMuMG epithelial cells.
Cells were induced to migrate, were fixed, and were immunolabeled with
Texas Red-conjugated phalloidin as in Fig. 4. EGFP-paxillin was
visualized by fluorescence from the EGFP tag. The merged images of the
EGFP tag (green) and F-actin (red) are shown.
Images showing cells expressing EGFP-paxillin (left
column), 2X mutant (middle column), and 2Y mutant
(right column) were generated as described under
"Experimental Procedures." Time after scratching is shown on the
left. At about 16 h after scratching (16 h), cells
migrating from each side of the wound began making contact with each
other. Scale bar represents 20 µm.
|
|

View larger version (76K):
[in this window]
[in a new window]
|
Fig. 6.
Intracellular localization of EGFP-tagged
paxillin during cell migration of NMuMG
epithelial cells. Fluorescence from the EGFP tag of wild-type
(A), 2X mutant (B), and 2Y mutant (C)
of paxillin in migrating NMuMG epithelial cells was traced using
time-lapse fluorescent microscopy as described under "Experimental
Procedures." The time, in minutes, elapsed following initiation of
the trace is shown in each figure. Arrowheads indicate the
paxillin-containing macroaggregates formed at cell periphery.
Scale bar represents 20 µm.
|
|

View larger version (64K):
[in this window]
[in a new window]
|
Fig. 7.
Altered subcellular localization of YF
mutants of EGFP-paxillin in motile NMuMG
cells. A, merged images of differential interference
contrast images (gray) with EGFP-paxillin visualized by
fluorescence from the EGFP tag (green). wt, wild
type. B, merged images of EGFP-paxillin (green) and paxillin generated by immunolabeling with
anti-paxillin antibody coupled with Cy3-conjugated anti-mouse IgG
(red). C, merged images of EGFP-paxillin (green) and F-actin visualized with Texas Red-X phalloidin
(red) in the mesenchymal phenotype of NMuMG cells.
Scale bars represent 20 µm.
|
|
The 2Y mutant also exhibited alterations that were substantially
different from those seen with the 2X mutant (Fig. 5). Similar to the
wild-type cells, most of the paxillin-containing focal adhesions, each
connected to actin stress fibers, were formed several micrometers away
from the cell periphery. Lateral localization of paxillin along the
cell periphery was also observed. However, orientations of actin stress
fibers were much more chaotic than in the 2X cells; most of them
crisscrossed with each other, and each focal adhesion structure was
often connected to multiple stress fibers, which again seemed to be
highly bundled. Moreover, disorganized membrane ruffles appeared to
occur in random directions (see Figs. 5, 6C, and
7A). Thus, expression of the 2Y mutant appears to disrupt
aspects of normal cell polarity.
At about 16 h after the scratching, cells migrating from each side
of the wound began to make contact with each other. At the initial
point of these cell contacts, wild-type EGFP-paxillin almost
disappeared from cell-cell junctions, coinciding with the disappearance
of most of the paxillin-containing focal adhesions. On the other hand,
cells expressing the 2X or the 2Y mutants still formed
paxillin-containing focal adhesions, which were connected to actin
stress fibers (Fig. 5).
Intracellular Dynamics of Paxillin during Cell Migration--
We
also traced intracellular dynamics of EGFP-paxillin
using a
fluorescence microscope with time-lapse video recording capacities. By
using this technique, we found that as a cell body extended forward,
most paxillin-containing focal adhesions seem to be formed as a
consequence of the accumulation of paxillin molecules that are formerly
localized laterally along the cell periphery (Fig. 6A). Video recording of the initial phases of cell migration
(0-30 min after generating the scratch) also supported this notion
(data not shown). We found similar results with cells expressing the 2Y
mutant (Fig. 6C). In contrast, cells expressing the 2X
mutant formed paxillin-containing macroaggregates directly at or very near to the cell periphery without prior localization laterally along
the cell periphery (Fig. 6B).
It is interesting to note that the subcellular localization of the
endogenous paxillin appeared to exhibit alterations that were similar
to those observed for the 2X and 2Y mutant (Fig. 7B).
Indeed, images of cellular paxillin (both endogenous and EGFP-paxillin), as detected by anti-paxillin antibody labeling, merged
almost completely with that of the fluorescence obtained from the EGFP tag.
Finally, NMuMG cells with the mesenchymal phenotype were also examined
(Fig. 7C). Most of the paxillin-containing focal adhesions connected to actin stress fibers were formed at least several micrometers away from the cell periphery, as seen with the epithelial phenotype. On the other hand, as in the case of the 2X mutant in the
epithelial phenotype, mesenchymal cells expressing the 2X mutant formed
paxillin-containing focal adhesions at or very close to the cell
periphery. Similarly, actin stress fibers in mesenchymal cells
expressing the 2Y mutant exhibited a more chaotic organization and
orientation, whereas the paxillin-containing focal adhesions formed
several micrometers away from the cell periphery.
 |
DISCUSSION |
Regulation of focal adhesion formation and actin-based
cytoskeletal organization are crucial events for facilitating cell migration. In this paper, we showed that tyrosine phosphorylation of
paxillin
plays an important role in these signal transduction events. We demonstrated that tyrosine phosphorylation events on multiple sites of paxillin
play a critical role in the formation of
paxillin-containing focal adhesions, as well as actin cytoskeletal organization in motile cells.
Multiple Sites of Tyrosine Phosphorylation Appear to Be Essential
for the Normal Function of Paxillin
--
Our results demonstrate
that four tyrosines (tyrosines 31, 40, 118, and 181) serve as major
phosphorylation sites of paxillin
in NMuMG cells. In addition,
phosphorylation on two of these sites, tyrosines 31 and 118, is
inducible upon integrin activation during EMT or cell migration. We
primarily characterized the 2X and 2Y mutants in this paper, and we
showed that both mutants affect paxillin-containing focal adhesion
formation and actin cytoskeletal organization. We also made a YF mutant
(2Y') possessing Tyr to Phe substitutions at Tyr-40 and Tyr-181
(Tyr-31, Tyr-118, Tyr-434, and Tyr-488 remained intact), and we
confirmed that this mutation also evoked essentially the same
phenotypes as described with the 2Y mutation in this paper (data not
shown). We have also made a series of mutants in which each of the four
tyrosine residues was mutated singly or in combinations, and we found
that they affected actin cytoskeletal organization and/or other
functions of paxillin.2
Moreover, we also made the 2X, 2Y, and 2Y' mutants without the EGFP tag
and confirmed the same effects (data not shown). Our results thus
collectively suggested that phosphorylation on these four tyrosines is
necessary for the proper function of paxillin
.
The 2X and 2Y mutations cause dramatic alterations in the intracellular
behavior of paxillin molecules in motile NMuMG cells, which was
accompanied by altered organization of both focal adhesions and
F-actin. Despite these dramatic changes, expression of the 2X or 2Y
mutants did not appreciably alter expression levels of several other
adhesion marker proteins, such as E-cadherin, integrin, fibronectin,
and vimentin.2 Moreover, since the 2X and 2Y mutants also
affected the positioning of focal adhesions in cells exhibiting the
mesenchymal phenotype, these YF mutants did not simply induce EMT in
these cells.
The hypothesis that individual phosphorylation sites may contribute to
different functions of paxillin in the cell is suggested by the fact
that cells expressing the 2X and 2Y mutants exhibited very different
phenotypes. Indeed, it is likely that different signaling molecules may
bind to these tyrosine phosphorylation sites, as expected from the
different primary structures surrounding each phosphorylation site.
Several proteins bearing SH2 domains, including the CrkI/CrkII and CrkL
proteins, have been implicated in binding to tyrosine phosphorylation
sites of paxillin (33, 41-43). We confirmed that the SH2 domain of
CrkI/CrkII can bind in vitro to tyrosine-phosphorylated
paxillin
prepared from NMuMG cells.2 However, CrkI and
CrkII proteins did not form a stable complex with paxillin in NMuMG
cells in vivo, whereas Crk II associates stably with several
other tyrosine-phosphorylated proteins, such as p130Cas,
c-Abl, Cbl, and Fak.2 This observation is consistent with
several other reports using other types of cells (42, 44). We also
found no evidence for the stable complex formation of CrkL with
paxillin in NMuMG cells.2 Further analysis is required to
determine which signaling proteins bind to and act downstream of the
tyrosine phosphorylation sites of paxillin
in NMuMG cells.
Intracellular Dynamics of Paxillin Localization to the Cell
Periphery and Formation of Focal Adhesion Aggregates--
Paxillin is
localized at the cell periphery, at focal adhesions, and in the
cytoplasm of normal motile NMuMG cells exhibiting the epithelial
phenotype. Interestingly, paxillin-containing focal adhesions are not
formed at the cell periphery in NMuMG cells but rather are formed at
least several micrometers away from the cell periphery. Consequently,
the lamellipodium structure that associates with areas of membrane
ruffling appears to form at the leading edge of the motile cells, as
has been previously described (45, 46). Our time course study indicates
that the peripheral localization of paxillin is observed from the early
phase of cell migration, whereas paxillin-containing focal adhesions
are formed later. Moreover, a fluorescence microscope-coupled
time-lapse video recording implies that most of paxillin-containing
focal adhesions are formed as a consequence of the accumulation of
paxillin molecules that were formerly localized laterally along the
cell periphery. Therefore, most paxillin molecules seem to be recruited first to the cell periphery, then aggregate with each other, and finally form focal adhesions that are at that point connected to actin
stress fibers. This process seems to be tightly coupled with forward
extension of the cell body.
NMuMG cells exhibiting the mesenchymal phenotype, on the other hand,
showed a different subcellular localization of paxillin in that these
cells possess lower levels of peripheral paxillin. However, focal
adhesions are still formed away from the cell periphery, allowing the
lamellipodium structure to be formed at the leading edge of these
cells. In other types of cells, such as NIH3T3 or 3Y1 fibroblasts,
paxillin exists at cell periphery, but most of the paxillin is found in
focal adhesion-like structures that are frequently connected to actin
stress fibers. Furthermore, expression of the 2X mutant in 3Y1 cells
did not cause alteration of focal adhesion formation nor of the actin
cytoskeleton. Finally, almost all paxillin-containing focal adhesions
disappear in NMuMG epithelial cells when they are grown to confluence,
whereas substantial levels of these structures remain in cells
exhibiting the mesenchymal phenotype. Therefore, the intracellular
dynamics of paxillin seem to be regulated differently among different
cell types. In NMuMG cells, paxillin regulation occurs in a cell
density and cell phenotype-dependent manner.
Tyrosine Phosphorylation of Paxillin
and Temporospatial
Regulation of Focal Adhesion Formation and Actin Cytoskeletal
Organization--
We showed in situ that paxillin
molecules, which are localized at cell periphery or at focal adhesions,
are tyrosine-phosphorylated. In wild-type NMuMG cells or cells
expressing the 2X or 2Y mutants, focal adhesions disappeared in cells
of the epithelial phenotype when they are grown to confluence. However,
unlike in wild-type cells, in cells expressing the 2X mutant, most of
the paxillin-containing focal adhesions formed at the cell periphery
without prior localization laterally along the cell periphery. Thus,
the 2X mutation may facilitate aggregation of paxillin molecules or act
to inhibit paxillin translocation to sites that are localized laterally
along the cell periphery. On the other hand, cells expressing the 2Y mutant exhibited disorganized actin stress fibers accompanied by the
loss of cell polarity, whereas focal adhesions formed in a manner
similar to that observed in the wild-type cells. We also examined
migration speeds as assessed by two-dimensional free locomotion on
culture dishes, and we found that expression of the 2X or 2Y mutants
did not significantly alter the migratory activity as compared with the
expression of wild-type EGFP-paxillin
in NMuMG
cells.2
Several tyrosine kinases have been implicated in paxillin
phosphorylation (24-26). Formation of a complex between paxillin and
Fak appears to be required for maximal phosphorylation in response to
cell adhesion in fibroblasts (47), although Fak may not be the sole
tyrosine kinase that phosphorylates paxillin (37) or Fak may rather act
to direct paxillin phosphorylation by recruiting Src family kinases
(24, 47). Pyk2, another tyrosine kinase acting in integrin signaling,
has also been shown to associate with paxillin (48, 49). However, it is
not yet established which kinase phosphorylates paxillin. Our analysis
revealed that Fak is tyrosine-phosphorylated and thus activated in
NMuMG cells of both epithelial and mesenchymal phenotypes (see Fig.
2).2 Likewise, a fraction of c-Src also appears to be
constantly activated.2 On the other hand, we found that
Pyk2 becomes highly phosphorylated and thus activated during
EMT.2 Pyk2 may therefore also be responsible for the
phosphorylation of Tyr-31 and Tyr-118 of paxillin. Identification of
the kinase(s) that phosphorylates paxillin during cell migration will
contribute to the understanding of the regulations of cytoskeletal
organization and cell polarity. It also remains to be established
whether integrins or distinct transmembrane proteins serve as surface
receptors regulating tyrosine phosphorylation of paxillin that
localizes laterally along the cell periphery.
Possible Relationship between Rho Family GTPases and Downstream
Signaling of Tyrosine-phosphorylated Paxillin--
Many questions
regarding the dynamics of paxillin localization during cell migration
remain to be answered. For example, (i) how is paxillin colocalized
with circumferential actin filaments, laterally along the cell
periphery, without forming macroaggregates? (ii) What regulates the
timing and positioning involved in the formation of paxillin-containing
focal adhesions? (iii) How is the connection of actin stress fibers to
paxillin-containing focal adhesions then regulated, and what role(s)
does it play? Each of these questions requires more insight into the
signal transduction pathways that regulate paxillin function. It has
been well documented that actin polymerization and focal adhesion
assembly are two distinct downstream effects of Rho family GTPases
(50). It has been also demonstrated that the activity of different Rho
family GTPases determines whether phosphotyrosine-containing proteins, including vinculin and paxillin, form focal complexes along the cell
periphery or form focal adhesions connected to stress fibers (45, 50).
A number of studies attempting to elucidate the precise molecular
mechanisms for these processes have been reported. For example, one
line of evidence suggests that Cdc42 acts to restrict Rac activity
through the generation of a polarizing signal, thereby preventing the
Rac protein from otherwise initiating the protrusion of lamellipodia
around the cell periphery (46). The Arp2/3 complex, one of the
effectors of Cdc42, has been shown to regulate the nucleation of linear
filamentous actin polymerization and the formation of branching
networks of actin filaments (51-55). Possible intercommunication
between paxillin and Cdc42 and/or other Rho family GTPases has been
implicated based on the finding that paxillin can indirectly associate
with p21 GTPase-activated kinase 3 (PAK3) and the guanine nucleotide
exchange factor,
PIX, although tyrosine phosphorylation of paxillin
is not required for this association (56). We observed that NMuMG cells
expressing the 2X mutant can form filopodia structures, whereas the 2Y
mutation results in a substantial loss in cell polarity. Filopodia
formation and the generation of a polarizing signal are both regulated
by Cdc42 activity (50, 57). Thus our observations are consistent with
the possibility that intercommunication between paxillin and Cdc42
plays an important role in regulating cytoskeletal dynamics.
 |
ACKNOWLEDGEMENTS |
We thank Manami Hiraishi, Mihoko Sato, and
Asako Tsubouchi for technical assistance and Mayumi Yoneda for
secretarial work. We also thank to Warren Pear and David Baltimore for
BOSC23 cells; Hermut Land for pBabe vector; Hisamaru Hirai for
anti-p130Cas antibody; and Heidi Greulich for critical
reading of the manuscript.
 |
FOOTNOTES |
*
This work was supported in part by Japan Science and
Technology Corp., grants-in-aid from the Ministry of Education,
Science, Sports and Culture of Japan, grants from the Mitsubishi
Foundation, the Ciba-Geigy Foundation (Japan) for the Promotion of
Science, the Takeda Medical Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and the Novartis Foundation for the Promotion of Science.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed: Dept. of Molecular
Biology, Osaka Bioscience Institute, 6-2-4 Furuedai, Suita, Osaka
565-0874, Japan. Tel.: 81-6-6872-4814; Fax: 81-6-6871-6686; E-mail:
sabe@obi.or.jp.
Published, JBC Papers in Press, May 23, 2000, DOI 10.1074/jbc.M000679200
2
H. Yano, K. Nakamura, H. Uchida, S. Hashimoto,
and H. Sabe, unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
EMT, epithelial-mesenchymal trans-differentiation;
EGFP, enhanced green
fluorescent protein;
Fak, focal adhesion kinase;
SH2, src
homology 2;
PAGE, polyacrylamide gel electrophoresis;
Ab, antibody.
 |
REFERENCES |
| 1.
|
Hynes, R. O.
(1992)
Cell
69,
11-25
|
| 2.
|
Lauffenburger, D. A.
(1994)
Appl. Mech. Rev.
47,
287-290
|
| 3.
|
Lauffenburger, D. A.,
and Horwitz, A. F.
(1996)
Cell
84,
359-369
|
| 4.
|
Sheetz, M. P.,
Felsenfeld, D. P.,
and Galbraith, C. G.
(1998)
Trends Cell Biol.
8,
51-54
|
| 5.
|
Chicurel, M. E.,
Chen, C. S.,
and Ingber, D. E.
(1998)
Curr. Opin. Cell Biol.
10,
232-239
|
| 6.
|
Ridley, A. J.,
and Hall, A.
(1992)
Cell
70,
389-399
|
| 7.
|
van Aelst, L.,
and D'Souza-Schorey, C.
(1997)
Genes Dev.
11,
2295-2322
|
| 8.
|
Hall, A.
(1998)
Science
279,
509-514
|
| 9.
|
Peters, P. J.,
Hsu, V. W.,
Ooi, C. E.,
Finazzi, D. B.,
Teal, S.,
Oorschot, V.,
Donaldson, J. G.,
and Klausner, R. D.
(1995)
J. Cell Biol.
128,
1003-1017
|
| 10.
|
Radhakrishna, H.,
and Donaldson, J. G.
(1997)
J. Cell Biol.
139,
49-61
|
| 11.
|
Norman, J. C.,
Jones, D.,
Barry, S. T.,
Holt, M. R.,
Cockcroft, S.,
and Critchley, D. R.
(1998)
J. Cell Biol.
143,
1981-1995
|
| 12.
|
Radhakrishna, H.,
Al-Awar, O.,
Khachikian, Z.,
and Donaldson, J. G.
(1999)
J. Cell Sci.
112,
855-866
|
| 13.
|
Hay, E. D.,
and Zuk, A.
(1995)
Am. J. Kidney Dis.
26,
678-690
|
| 14.
|
Hay, E. D.
(1995)
Acta Anat.
154,
8-20
|
| 15.
|
Clark, E. A.,
and Brugge, J. S.
(1995)
Science
268,
233-239
|
| 16.
|
Schwartz, M. A.,
Schaller, M. D.,
and Ginsberg, M. H.
(1995)
Annu. Rev. Cell Dev. Biol.
11,
549-599
|
| 17.
|
Parsons, J. T.
(1996)
Curr. Opin. Cell Biol.
8,
146-152
|
| 18.
|
Burridge, K.,
and Chrzanowska-Wodnicka, M.
(1996)
Annu. Rev. Cell Dev. Biol.
12,
463-518
|
| 19.
|
Horwitz, A. R.,
and Parsons, J. T.
(1999)
Science
286,
1102-1103
|
| 20.
|
Porter, J. C.,
and Hogg, N.
(1998)
Trends Cell Biol.
8,
390-396
|
| 21.
|
Burridge, K.,
Turner, C. E.,
and Romer, L. H.
(1992)
J. Cell Biol.
119,
893-903
|
| 22.
|
Mazaki, Y.,
Hashimoto, S.,
and Sabe, H.
(1997)
J. Biol. Chem.
272,
7437-7444
|
| 23.
|
Mazaki, Y.,
Uchida, H.,
Hino, O.,
Hashimoto, S.,
and Sabe, H.
(1998)
J. Biol. Chem.
273,
22435-22441
|
| 24.
|
Richardson, A.,
Malik, R. K.,
Hildebrand, J. D.,
and Parsons, J. T.
(1997)
Mol. Cell Biol.
17,
6906-6914
|
| 25.
|
Bellis, S. L.,
Miller, J. T.,
and Turner, C. E.
(1995)
J. Biol. Chem.
270,
17437-17441
|
| 26.
|
Thomas, S. M.,
Soriano, P.,
and Imamoto, A.
(1995)
Nature
376,
267-271
|
| 27.
|
Graham, I. L.,
Anderson, D. C.,
Holers, V. M.,
and Brown, E. J.
(1994)
J. Cell Biol.
127,
1139-1147
|
| 28.
|
Turner, C. E.
(1998)
Int. J. Biochem. Cell Biol.
30,
955-959
|
| 29.
|
Tong, X.,
and Howley, P. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
4412-4417
|
| 30.
|
Tong, X.,
Salgia, R.,
Li, J. L.,
Griffin, J. D.,
and Howley, P. M.
(1997)
J. Biol. Chem.
272,
33373-33376
|
| 31.
|
Miettinen, P. J.,
Ebner, R.,
Lopez, A. R.,
and Derynck, R.
(1994)
J. Cell Biol.
127,
2021-2036
|
| 32.
|
Morgenstern, J. P.,
and Land, H.
(1990)
Nucleic Acids Res.
18,
3587-3596
|
| 33.
|
Turner, C. E.,
and Miller, J. T.
(1994)
J. Cell Sci.
107,
1583-1591
|
| 34.
|
Pear, W. S.,
Nolan, G. P.,
Scott, M. L.,
and Baltimore, D.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
8392-8396
|
| 35.
|
Sabe, H.,
Hata, A.,
Okada, M.,
Nakagawa, H.,
and Hanafusa, H.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
3984-3988
|
| 36.
|
Tobe, K.,
Sabe, H.,
Yamamoto, T.,
Yamauchi, T.,
Asai, S.,
Kaburagi, Y.,
Tamemoto, H.,
Ueki, K.,
Kimura, H.,
Akanuma, Y.,
Yazaki, Y.,
Hanafusa, H.,
and Kadowaki, T.
(1996)
Mol. Cell. Biol.
16,
4765-4772
|
| 37.
|
Ilic, D.,
Furuta, Y.,
Kanazawa, S.,
Takeda, N.,
Sobue, K.,
Nakatsuji, N.,
Nomura, S.,
Fujimoto, J.,
Okada, M.,
and Yamamoto, T.
(1995)
Nature
377,
539-544
|
| 38.
|
Cary, L. A.,
Han, D. C.,
Polte, T. R.,
Hanks, S. K.,
and Guan, J. L.
(1998)
J. Cell Biol.
140,
211-221
|
| 39.
|
Klemke, R. L.,
Leng, J.,
Molander, R.,
Brooks, P. C.,
Vuori, K.,
and Cheresh, D. A.
(1998)
J. Cell Biol.
140,
961-972
|
| 40.
|
Honda, H.,
Oda, H.,
Nakamoto, T.,
Honda, Z.,
Sakai, R.,
Suzuki, T.,
Saito, T.,
Nakamura, K.,
Nakao, K.,
Ishikawa, T.,
Katsuki, M.,
Yazaki, Y.,
and Hirai, H.
(1998)
Nat. Genet.
19,
361-365
|
| 41.
|
Butler, A. A.,
Blakesley, V. A.,
Koval, A.,
deJong, R.,
Groffen, J.,
and LeRoith, D.
(1997)
J. Biol. Chem.
272,
27660-27664
|
| 42.
|
Salgia, R.,
Uemura, N.,
Okuda, K.,
Li, J. L.,
Pisick, E.,
Sattler, M.,
de Jong, R.,
Druker, B.,
Heisterkamp, N.,
Chen, L. B.,
Groffen, J.,
and Griffin, J. D.
(1995)
J. Biol. Chem.
270,
29145-29150
|
| 43.
|
Ribon, V.,
and Saltiel, A. R.
(1996)
J. Biol. Chem.
271,
7375-7380
|
| 44.
|
Nakashima, N.,
Rose, D. W.,
Xiao, S.,
Egawa, K.,
Martin, S. S.,
Haruta, T.,
Saltiel, A. R.,
and Olefsky, J. M.
(1999)
J. Biol. Chem.
274,
3001-3008
|
| 45.
|
Small, J. V.,
Rottner, K.,
and Kaverina, I.
(1999)
Curr. Opin. Cell Biol.
11,
54-60
|
| 46.
|
Waterman-Storer, C. M.,
and Salmon, E. D.
(1999)
Curr. Opin. Cell Biol.
11,
61-67
|
| 47.
|
Thomas, J. W.,
Cooley, M. A.,
Broome, J. M.,
Salgia, R.,
Griffin, J. D.,
Lombardo, C. R.,
and Schaller, M. D.
(1999)
J. Biol. Chem.
274,
36684-36692
|
| 48.
|
Salgia, R.,
Avraham, S.,
Pisick, E.,
Li, J. L.,
Raja, S.,
Greenfield, E. A.,
Sattler, M.,
Avraham, H.,
and Griffin, J. D.
(1996)
J. Biol. Chem.
271,
31222-31226
|
| 49.
|
Ostergaard, H. L.,
Lou, O.,
Arendt, C. W.,
and Berg, N. N.
(1998)
J. Biol. Chem.
273,
5692-5696
|
| 50.
|
Nobes, C. D.,
and Hall, A.
(1995)
Cell
81,
53-62
|
| 51.
|
Ma, L.,
Rohatgi, R.,
and Kirschner, M. W.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
15362-15367
|
| 52.
|
Mullins, R. D.,
Heuser, J. A.,
and Pollard, T. D.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
6181-6186
|
| 53.
|
Bailly, M.,
Macaluso, F.,
Cammer, M.,
Chan, A.,
Segll, J. E.,
and Condeelis, J. S.
(1999)
J. Cell Biol.
145,
331-345
|
| 54.
|
Svitkina, T. M.,
and Borisy, G. G.
(1999)
J. Cell Biol.
145,
1009-1026
|
| 55.
|
Rohatgi, R. L. M.,
Miki, H.,
Lopez, M.,
Kirchhausen, T.,
Takenawa, T.,
and Kirschner, M. W.
(1999)
Cell
97,
221-231
|
| 56.
|
Turner, C. E.,
Brown, M. C.,
Perrotta, J. A.,
Riedy, M. C.,
Nikolopoulos, S. N.,
Mcdonald, A. R.,
Bagrodia, S.,
Thomas, S.,
and Leventhal, P. S.
(1999)
J. Cell Biol.
145,
851-863
|
| 57.
|
Nobes, C. D.,
and Hall, A.
(1999)
J. Cell Biol.
144,
1235-1244
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. R. Wylie and P. D. Chantler
Myosin IIC: A Third Molecular Motor Driving Neuronal Dynamics
Mol. Biol. Cell,
September 1, 2008;
19(9):
3956 - 3968.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Handfield, H.V. Baker, and R.J. Lamont
Beyond Good and Evil in the Oral Cavity: Insights into Host-Microbe Relationships Derived from Transcriptional Profiling of Gingival Cells
J. Dent. Res.,
March 1, 2008;
87(3):
203 - 223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Badowski, G. Pawlak, A. Grichine, A. Chabadel, C. Oddou, P. Jurdic, M. Pfaff, C. Albiges-Rizo, and M. R. Block
Paxillin Phosphorylation Controls Invadopodia/Podosomes Spatiotemporal Organization
Mol. Biol. Cell,
February 1, 2008;
19(2):
633 - 645.
|